Quality risk management (QRM) is a crucial process for ensuring the safety and efficacy of drugs throughout their lifecycle, from development to commercial manufacturing. By proactively identifying and managing potential risks, manufacturers can minimize the likelihood of quality issues and ensure the final product is high-quality and safe for patient use. Implementing a QRM process involves a structured approach to risk assessment, management, and control, as well as ongoing monitoring and reassessment of identified risks. In this blog post, we dive deeper into the topic of QRM and explore its importance in the pharmaceutical industry.
According to the International Council for Harmonisation (ICH), QRM foundations are supported by two primary principles:
This process should be considered in a holistic, proactive, and systematic manner, meaning QRM should be an integral part of the pharmaceutical quality system, focused on identifying and evaluating potential risks throughout the product lifecycle. Being proactive involves anticipating and addressing potential risks before they occur, while a systematic approach requires a structured, consistent methodology for identifying, assessing, controlling, and communicating risks. Risk management should also include continuous monitoring and reassessment to ensure risk management strategies remain effective.
Figure 1 – Overview of a typical QRM Process (ICH, 2023)
As an initial phase of a QRM process, subject matter experts (SMEs) must ensure a clear set of premises to guarantee an efficient risk assessment exercise, including the correct description of the problem, its scope, and the goal of the risk assessment. This characterization facilitates selection of the most appropriate QRM tools from the set of structured and standardized tools that any organization should have available.
This post divides these risk management tools into three categories, highlighting the benefits and limitations of each QRM strategy and providing suggestions for their ideal application:
Simple brainstorming tools are the most commonly used tools in a QRM process, whether for gathering data and information or characterizing the process, product, or entity being assessed. These tools are often used in the initial steps of a QRM workflow and can serve as prerequisites to more risk-focused analysis and complex risk classification.
| Process Mapping | Decision Trees | Mind Maps | The 5 Whys |
|---|---|---|---|
| A schematic display of process steps presented sequentially, defining resources and potential outcomes. |
A semi-linear, branched flowchart illustrating possible outcomes and decision alternatives for a specific problem. |
A diagram organized around a central concept, with branching elements that generate keywords and discussion points. | A structured questioning technique that asks “Why?” five times, with each answer forming the basis of the next question. |
| Big Benefit: Completely standardizes work processes from beginning to end. | Big Benefit: Assigns specific values to each problem, decision path or outcome. | Big Benefit: Promotes meaningful learning by connecting new knowledge to existing knowledge. | Big Benefit: Effectively identifies and analyzes the root cause of a problem or deviation. |
| Expert Advice: Include process measurements, such as the time required for each step. | Expert Advice: Recognize that the final outcome of one decision tree often becomes the starting point for another decision. | Expert Advice: Use mind maps when a less sequential, more associative approach than traditional process mapping is beneficial. | Expert Advice: Clearly distinguish root causes from symptoms or contributing factors. |
Although their influence is often less direct than risk analysis or risk classification tools, these simple brainstorming tools can be critical for planning subsequent QRM activities or serving as complementary follow-ups to more in-depth analyses. For example, describing multiple associations between a problem and potential impacts using a mind map can support later cause-and-effect analysis, allowing ranking of those associations and focus on the most impactful ones.
Despite being referred to as "simple tools," these offer a much more sophisticated approach than basic brainstorming by enabling cause-and-effect risk analysis. This analytical process is crucial for identifying potential risks and understanding the relationships among various risk factors, thereby facilitating a comprehensive and effective risk management strategy.
| Ishikawa (“Fishbone”) Diagram | Cause-and-Effect Matrix |
|---|---|
| A simple branching diagram that focuses on the most influential inputs affecting each output. | A matrix that evaluates all possible inputs and outputs to establish and quantify their relationships. |
|
Benefits:
|
Benefits:
|
|
Limitations:
|
Limitations:
|
The fishbone diagram, originally developed by Kaoru Ishikawa in the 1960s, has become a valuable tool for quality management in drug manufacturing and development. It maps potential quality control issues and identifies contributing causal factors, represented as “bones,” that lead to a defined outcome, represented by the “head.” By utilizing the fishbone diagram, manufacturers can identify and manage potential risks throughout the product lifecycle.
Figure 2 – Example of a fishbone diagram
Similarly, the cause-and-effect matrix evaluates the relationships between causal factors and their effects. While it is well suited for assessing problems involving multiple causal factors, it may not illustrate interrelated patterns as effectively as visual tools. Nonetheless, both simple risk analysis tools are important for informing more advanced QRM tools and building an effective quality management system (QMS).
The most complex QRM tools are designed to classify previously identified by assessing their severity, occurrence, and detection (SOD). Using the gathered knowledge about each process parameter, correlation, and potential hazard, the goal is to answer these three questions:
The result is the risk priority number (RPN), a combined calculation of SOD used to quantify and prioritize the risk of each failure mode.
| Preliminary Hazard Analysis (PHA) Ideal for analyzing different systems during the early stages of product development. |
Failure Mode and Effects Analysis (FMEA) An assessment of possible failure modes and their effects on product quality and performance. |
|---|---|
|
Steps:
|
Steps:
|
|
Benefits:
|
Benefits:
|
|
Limitations:
|
Limitations:
|
PHA is especially useful in early design phases when modifications are more cost-effective and easier to implement. By anticipating delays and addressing them earlier in the development pipeline, the PHA can also reduce design time.
Similarly, FMEA proactively identifies and addresses potential problems before they arise. Although FMEA is the most resource-intensive and time-consuming of the QRM tools, it can serve as the foundation for system design elements and process controls across the entire product pipeline. By utilizing PHA and FMEA, manufacturers can optimize their development processes and produce higher-quality products with improved safety profiles.
Managing risk effectively can be challenging, particularly when the QRM process is not systematically organized across the organization. This underscores the need for a dedicated QRM system that streamlines and centralizes all activities related to identifying, quantifying, and prioritizing risks.
Quality risk management digitalization consolidates these activities into a single platform. When implemented correctly, this approach enables a centralized and holistic QRM process that connects the organization, ensures process coherence, and facilitates knowledge preservation and reuse.
By optimizing your QRM process through digitalization, you can improve efficiency and elevate your product development and manufacturing operations.
Ready to learn more? Read Digital Quality Risk Management: A ValGenesis Story or watch the webinar featured below.